Related Experiment Video
Updated: Jun 21, 2026
12:49
Purification of Transcripts and Metabolites from Drosophila Heads
Published on: March 15, 2013
RNAi for the large non-coding hsromega transcripts suppresses polyglutamine pathogenesis in Drosophila models
Moushami Mallik1, Subhash C Lakhotia
1Cytogenetics Laboratory, Department of Zoology, Banaras Hindu University, Varanasi, India.
RNA Biology
|August 12, 2009
Summary
Downregulating hsromega-n RNA in Drosophila suppresses polyglutamine (polyQ) disease pathogenesis by reducing protein aggregation. This suggests hsromega transcripts are key in early polyQ aggregate formation and potential therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by expanded CAG trinucleotide repeats.
- Overexpression of non-coding hsromega transcripts enhances polyQ-induced cytotoxicity in Drosophila.
Purpose of the Study:
- To investigate the role of hsromega transcripts in polyQ disease pathogenesis.
- To determine if downregulating hsromega-n RNA can suppress polyQ-mediated neurodegeneration in Drosophila models.
Main Methods:
- Utilized RNA interference (RNAi) to downregulate hsromega-n transcripts in Drosophila models of polyQ diseases.
- Assessed suppression of eye-specific degeneration and premature death in flies expressing expanded polyQ transgenes.
- Analyzed polyQ protein aggregation, transgene transcription, and Hsp70 induction.
Main Results:
- RNAi-mediated downregulation of hsromega-n RNA suppressed eye degeneration and rescued premature death in multiple Drosophila polyQ models.
- Hsromega-n RNAi significantly reduced polyQ protein aggregation without affecting transgene transcription.
- Hsromega-n RNAi abolished Hsp70 induction in polyQ-expressing cells and had minimal effect on tau-induced neuropathy.
Conclusions:
- Hsromega transcripts play a role in the early stages of polyglutamine aggregate formation.
- Hsromega-n RNA downregulation is a potential therapeutic strategy for polyQ neurodegenerative diseases.
- Functional human analogues of hsromega transcripts are promising therapeutic targets.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
02:57piRNA - Piwi-interacting RNAs
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...